EUVIMEDEUVIMED entdecken
Crossref

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancer

Marianna Moro, Federica Carolina Balestrero, Giorgia Colombo, Simone Torretta, Nausicaa Clemente, Valerio Ciccone, Erika Del Grosso, Sandra Donnini, Cristina Travelli, Fabrizio Condorelli, Sabina Sangaletti, Armando A Genazzani und 1 weitere

Angiogenesis · 2025

DOI: 10.1007/s10456-024-09956-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiogenesis, 2025. Verfasst von Marianna Moro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Nicotinamide Phosphoribosyltransferase, Pericytes, Neovascularization, Pathologic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS, Fondazione Cariplo, Ministero dell'Istruzione, dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumour angiogenesis supports malignant cells with oxygen and nutrients to promote invasion and metastasis. A number of cytokines released in situ participate in the recruitment of endothelial cells and pericytes to trigger the formation of novel blood vessels, which are often abnormal, leaky, and disorganized. Nicotinamide phosphoribosyltransferase is a key intracellular enzyme involved in NAD metabolism and is up regulated in many cancers to meet bioenergetic demands. Yet, the same protein is also secreted extracellularly (eNAMPT), where it acts as a pro-inflammatory cytokine. High plasma eNAMPT levels have been reported in breast cancer patients and correlate with aggressiveness and prognosis. We now report that in a triple-negative breast cancer model, enriching the tumour microenvironment with eNAMPT leads to abundant angiogenesis and increased metastatization. Atypically, the eNAMPT-mediated pro-angiogenic effect is mainly directed to NG2+ pericytes. Indeed, eNAMPT acts as chemoattractant for pericytes and coordinates vessel-like tube formation, in synergism with the classical factor PDGF-BB. Stimulation of pericytes by eNAMPT leads to a pro-inflammatory activation, characterized by the overexpression of key chemokines (CXCL8, CXCL1, CCL2) and VCAM1, via NF-κB signalling. All these effects were ablated by the use of C269, an anti-eNAMPT neutralizing antibody, suggesting that this might represent a novel anti-angiogenic pharmacological approach for triple-negative breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsNicotinamide PhosphoribosyltransferasePericytesNeovascularization, PathologicHumansFemaleAnimalsCell Line, TumorMiceTumor MicroenvironmentCytokines

Stichwörter der Autor:innen

AngiogenesisBreast cancerCytokinesPericytesTumour microenvironment

Substanzen

Nicotinamide Phosphoribosyltransferasenicotinamide phosphoribosyltransferase, humanCytokines

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy.
  • Division of Hematology/Oncology Department of Medicine, Weill Cornell Medicine, Cornell University, New York, USA.
  • Department of Health Science, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, Università del Piemonte Orientale, Novara, Italy.
  • Department of Life Science, Università di Siena, Siena, Italy.
  • Department of Drug Sciences, Università degli Studi di Pavia, Pavia, Italy.
  • Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Förderung

  • Fondazione AIRC per la ricerca sul cancro ETS
  • Fondazione Cariplo
  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Moro, M., Balestrero, F. C., Colombo, G., Torretta, S., Clemente, N., Ciccone, V., Del Grosso, E., Donnini, S., Travelli, C., Condorelli, F., Sangaletti, S., Genazzani, A. A., & Grolla, A. A. (2025). Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancer. Angiogenesis. https://doi.org/10.1007/s10456-024-09956-2

Vancouver

Moro M, Balestrero FC, Colombo G, Torretta S, Clemente N, Ciccone V, et al. Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancer. Angiogenesis. 2025. doi:10.1007/s10456-024-09956-2

BibTeX
@article{Moro2025,
  author = {Moro, Marianna and Balestrero, Federica Carolina and Colombo, Giorgia and Torretta, Simone and Clemente, Nausicaa and Ciccone, Valerio and Del Grosso, Erika and Donnini, Sandra and Travelli, Cristina and Condorelli, Fabrizio and Sangaletti, Sabina and Genazzani, Armando A and Grolla, Ambra A},
  title = {Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancer},
  journal = {Angiogenesis},
  year = {2025},
  doi = {10.1007/s10456-024-09956-2}
}
Kostenlos starten →